Nilotinib (Tasigna) is a novel targeted tumor therapy drug, belonging to tyrosine kinase inhibitors. It is used to treat patients with chronic myeloid leukemia (CML) who are resistant to Gleevec (imat…
Lenvatinib methanesulfate is the methanesulfate of lenvatinib. Lenvatinib is a multi-target tyrosine kinase inhibitor developed by Eisai of Japan. It has a novel binding mode. In addition to inhibitin…
LEE011 (Ribociclib) is an inhibitor of cyclin D1 / CDK4 and CDK6, used for the treatment of certain types of breast cancer. It is also being studied as a method for treating other drug-resistant cance…
Dabrafenib, developed by GlaxoSmithKline (GSK) of the United States, is a drug for treating metastatic melanoma. It belongs to the BRAF inhibitor class of cancer drugs and is used in the form of mesyl…
Bosutinib is a potent protein kinase inhibitor that can not only inhibit the autonomous phosphorylation of Src proteins in various human tumor cells, but also suppress the phosphorylation process of S…
Bictelatvir (BIC) is a second-generation integrase chain transfer inhibitor (INSTI), which has been approved for fixed-dose combination with entecitabine and tenofovir alafenamiChemical Bookde for the…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea